IP Verse

Method Of Identifying Treatment Responsive Non Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker - EP2898329

PATENT ANALYSIS

Patent Details

Grant Date
May 17, 2017
Company
VENTANA MEDICAL SYSTEMS, INC.
Oppositions

HOFFMANN EITLE

More patents of Ventana Medical Systems, Inc.

EP3111221

EP3149481

EP2898329

Want to monitor this patent?

Feel free to send us a message here and we will get back to you